Anti-immunoglobulin
   HOME



picture info

Anti-immunoglobulin
Anti-immunoglobulin Antibody, antibodies are defined as a protein that detects other antibodies from an organism. Specifically, anti-immunoglobulin antibodies are created by B cell, B-cells as antibodies to bind to other immunoglobulins. Immunoglobulins have two regions: the constant region and the variable region. The constant region is involved in effector function, while the variable region is involved in recognizing and binding to antigens. Anti-immunoglobulin antibodies may bind to either the variable or constant region of the immunoglobulin. Anti-immunoglobulin antibodies are a type of secondary antibody. They are able to detect primary antibodies through multiple methods such as a Western blot, immunohistochemistry, Immunofluorescence, immunofluorescence staining, flow cytometry, and ELISA. Creation of Anti-immunoglobulin Antibodies The anti-immunoglobulin antibodies are created through recombinant DNA technology. Production via recombinant DNA technology allows the highest ...
[...More Info...]      
[...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]  




Omalizumab
Omalizumab, sold under the brand name Xolair among others, is an injectable medication to treat severe persistent allergic forms of asthma, nasal polyps, urticaria (hives), and immunoglobulin E-mediated food allergy. Omalizumab is a recombinant DNA-derived humanized IgG1 monoclonal antibody which specifically binds to free human immunoglobulin E (IgE) in the blood and interstitial fluid and to the membrane-bound form of IgE (mIgE) on the surface of mIgE-expressing B lymphocytes. Its primary adverse effect is anaphylaxis. In 1987, Tanox filed its first patent application on the anti-IgE drug candidate. Omalizumab was approved for medical use in the United States in June 2003, and authorized in the European Union in October 2005. Medical uses In the United States, omalizumab is indicated to treat moderate to severe persistent asthma; chronic rhinosinusitis with nasal polyps; immunoglobulin E (IgE)-mediated food allergy; and chronic spontaneous urticaria. In the Europe ...
[...More Info...]      
[...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]  



MORE